Brown, Lisle/Cummings’s Biohaven BHVN Stock Holding History

Brown, Lisle/Cummings’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$551	Hold	37	–	–	﹤0.01%	1016
2026 Q1	$313	Hold	37	–	–	﹤0.01%	1005
2025 Q4	$418	Hold	37	–	–	﹤0.01%	727
2025 Q3	$555	Hold	37	–	–	﹤0.01%	736
2025 Q2	$522	Hold	37	–	–	﹤0.01%	747
2025 Q1	$889	Hold	37	–	–	﹤0.01%	717
2024 Q4	$1.38K	Hold	37	–	–	﹤0.01%	612
2024 Q3	$1.85K	Hold	37	–	–	﹤0.01%	578
2024 Q2	$1.28K	Buy	+37	New	+$1.46K	﹤0.01%	578

Other funds holding BHVN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown, Lisle/Cummings's BHVN Position: Q2 2026 in Review

Brown, Lisle/Cummings held its Biohaven (BHVN) position steady in Q2 2026 at 37 shares worth $551. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Brown, Lisle/Cummings first reported a position in BHVN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.85K in Q3 2024. 296 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

Brown, Lisle/Cummings held 37 shares of Biohaven worth $551 as of Q2 2026.
Brown, Lisle/Cummings left its Biohaven share count unchanged in Q2 2026.
Biohaven made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #1016 holding.
Brown, Lisle/Cummings first reported a position in Biohaven in Q2 2024 and has held it in 9 quarters since.
Brown, Lisle/Cummings's Biohaven position peaked at $1.85K in Q3 2024.
296 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.